WebCytokinetics. Pharmaceuticals · California, United States · 253 Employees . Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. WebJan 7, 2024 · SOUTH SAN FRANCISCO, Calif. and NEW YORK, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Cytokinetics has ...
PRESS RELEASES Cytokinetics, Inc.
WebApr 10, 2024 · Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to TipRanks , Kumar has an average return of 17.8% and a 49 ... WebJan 11, 2024 · ClinicalTrials.gov Identifier: NCT05186818 Recruitment Status : Recruiting First Posted : January 11, 2024 Last Update Posted : March 13, 2024 See Contacts and Locations View this study on Beta.ClinicalTrials.gov Sponsor: Cytokinetics Collaborator: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. Information provided by (Responsible Party): ipv fact sheet
Cytokines - Latest research and news Nature
WebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & … WebFeb 17, 2024 · Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $62.54, representing a 47.2% upside. In a report issued on February 2, … WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%. orchestra clermont